Gambaran Penggunaan Obat Off-Label Pada Pasien Pediatrik Rawat Inap di Rumah Sakit

Teti Sutriati Tuloli, Nur Rasdianah, Andi Makkulawu, Dizky Ramadani Putri Papeo, Maimun Datau

Abstract


Off-label drugs can be interpreted as drugs that are used not in accordance with drug information, distribution permits and sales licenses from the Marketing Authorization (MA) related to indications, age, dosage, route of administration and contraindications. The use of off-label drugs in children occurs because of incomplete data on pharmacokinetics, pharmacodynamics and side effect of a drug. It is because clinical research in children is quite difficult and not in accordance with research ethics and morals, so it has the potential to cause errors in treatment and unwanted drug reactions. This study aims to describe the use of off-label drugs in hospitalized pediatric patients at RSUD of Dr. M.M Dunda Limboto, Gorontalo District, Gorontalo Province. This is an  observational study using cross sectional design and retrospective data collection. The sampling technique applies a purposive sampling technique with a total of 155 patients who meet the inclusion criteria during the January-June 2020 period. The finding shows that from 155 patient medical records, there are 172 (16,51%) off-label drug used with a total of 1042 drugs. The off-label drugs used in the indication category are 64,53%, the off-label drugs used in dose category are 17,44%, the off-label drugs used in age category are 14,53%, the off-label drugs used in route of administration category are 3,49% and the off-label drugs used in contraindications category are not found. The are the most off-label drugs used in each category, including domperidone (off-label in indications and dose), rhinofed (off-label in age) and salbutamol (off-label in route of administration).


Keywords


Off-Label Drugs; Marketing Authorisation (MA); Pediatric Patiens; purposive sampling

Full Text:

PDF

References


Wittich, Christopher M et al. “Ten common questions (and their answers) about off-label drug use.” Mayo Clinic proceedings vol. 87,10 (2012): 982-90. doi:10.1016/j.mayocp.2012.04.017

Pratiwi, Ami A., et al. "Peresepan Obat-obat Off-Label pada Pasien Anak Usia 0 Hingga 2 Tahun di Apotek Kota Bandung." Jurnal Farmasi Klinik Indonesia 2.2 (2013): 39-50.

Teigen, Arna, et al. "Off-label and unlicensed medicines to hospitalised children in Norway." Journal of Pharmacy and Pharmacology 69.4 (2017): 432-438.. https://Doi.Org/10.1111/Jphp.12581.

Setyaningrum, Ndaru, Viara Gredynadita, and Suci Gartina. "Penggunaan obat off-label pada anak di apotek kota Yogyakarta." Jurnal Sains Farmasi & Klinis 4.1 (2017): 30-35. https://doi.org/10.29208/jsfk.2017.4.1.169.

Tefera, Yonas G., et al. "Off‐label drug use in hospitalized children: a prospective observational study at Gondar University Referral Hospital, Northwestern Ethiopia." Pharmacology research & perspectives 5.2 (2017): e00304.https://doi.org/10.1002/prp2.304.

Zaidan, Zaidan, and Santriani Hadi. "Karakteristik Penderita Demam Tifoid di RS. Ibnu Sina Kota Makassar Tahun 2016-2017." UMI Medical Journal 5.1 (2020): 57-68. https://doi.org/10.33096/umj.v5i1.81.

Christy, Meivi Yusinta. "Faktor yang berhubungan dengan kejadian dehidrasi diare pada balita di wilayah kerja Puskesmas Kalijudan." Jurnal berkala epidemiologi 2.3 (2014): 297-308.

Rusli. Bahan Ajar Farmasi: Farmasi Klinik Edisi 2018. Kementerian Kesehatan Republik Indonesia : Makasar. (2018).

Eyers, Sally, et al. "British National Formulary for Children: the risk of inappropriate paracetamol prescribing." Archives of disease in childhood 97.3 (2012): 279-282. http://dx.doi.org/10.1136/archdischild-2011-300464.

Marchetti, Federico, et al. "Oral ondansetron versus domperidone for symptomatic treatment of vomiting during acute gastroenteritis in children: multicentre randomized controlled trial." BMC pediatrics 11.1 (2011): 1-9. https://doi.org/10.1186/1471-2431-11-15.

Global Initiative for Asthma (GINA). "Pocket guide for asthma management and prevention in children 5 years and younger." (2009).. Citting Internet Source URL https://ginasthma.org/pocket-guide-for-asthma-management-and-prevention-in-children-5-years-and-younger/.

Zanon, Davide, et al. "Off–label prescribing patterns of antiemetics in children: a multicenter study in Italy." European journal of pediatrics 172.3 (2013): 361-367. https://doi.org/10.1007/s00431-012-1894-2.

IONI. Informasi Obat Nasional Indonesia. Departemen Kesehatan RI. Jakarta. Citting Internet (Mei 01, 2020). Source URL http://pionas.pom.go.id/ioni.

Ramatillah, Diana Laila, and Aprilita Rinayanti Eff. "DRUG RELATED PROBLEMS THAT OCCURRED IN PATIENT SEPSIS MACROVASCULAR DISEASE COMPLICATIONS GENERAL HOSPITAL TREATMENT ROOM CENTRAL OF THE ARMY (ARMY HOSPITAL) GATOT SUBROTO." Wood Industry/Drvna Industrija 6.1 (2015).

Pappas, Diane E., and J. Owen Hendley. "The common cold and decongestant therapy." Pediatrics in review 32.2 (2011): 47-55. https://doi.org/10.1542/pir.32-2-47.

Agustina, Sri, Johanes Singoreto Widjaja, and Riska Puspasari. "Penggunaan Asam Valproat pada Pasien Epilepsi di Poliklinik Saraf Rumah Sakit Tingkat III Brawijaya Surabaya Periode Maret-Agustus 2021." Cermin Dunia Kedokteran 49.3 (2022): 126-128.

Ogden, Joy. "The British National Formulary: past, present and future." Prescriber 28.12 (2017): 20-24. https://doi.org/10.1002/psb.1632.

Ikawati, Zullies. "Farmakoterapi Penyakit Sistem Syaraf Pusat." (2011). Hal 85-102




DOI: https://doi.org/10.37311/ijpe.v2i2.11449

Refbacks

  • There are currently no refbacks.


Copyright (c) 2022 Teti Sutriati Tuloli, Nur Rasdianah, Andi Makkulawu, Dizky Ramadani Putri Papeo, Maimun Datau

Creative Commons License
Indonesian Journal of Pharmaceutical Education is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.